Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dieter Adam

Showing results (61-70 of 73) with videos related to

Pageof 8
Sort By:
Molecular and Cellular Biology|August 17, 2016
Differences and Similarities in TRAIL- and Tumor Necrosis Factor-Mediated Necroptotic Signaling in Cancer CellsJustyna Sosna, Stephan Philipp, Johaiber Fuchslocher Chico, et al.
Cancer Research|March 5, 2008
Anti-tumor necrosis factor therapy inhibits pancreatic tumor growth and metastasisJan-Hendrik Egberts, Vera Cloosters, Andreas Noack, et al.
Blood|May 27, 2011
Toso regulates the balance between apoptotic and nonapoptotic death receptor signaling by facilitating RIP1 ubiquitinationXuan-Hung Nguyen, Philipp A Lang, Karl S Lang, et al.
Autophagy|April 13, 2016
Excess sphingomyelin disturbs ATG9A trafficking and autophagosome closureElisabeth Corcelle-Termeau, Signe Diness Vindeløv, Saara Hämälistö, et al.
The European Respiratory Journal|April 22, 2022
Stimulation of the EP<sub>3</sub> receptor causes lung oedema by activation of TRPC6 in pulmonary endothelial cellsTian Jiang, Rudi Samapati, Sergej Klassen, et al.
Cardiovascular Research|June 13, 2014
RIP3, a kinase promoting necroptotic cell death, mediates adverse remodelling after myocardial infarctionMark Luedde, Matthias Lutz, Natalie Carter, et al.
Oncotarget|April 25, 2015
TRAIL-R2 promotes skeletal metastasis in a breast cancer xenograft mouse modelHendrik Fritsche, Thorsten Heilmann, Robert J Tower, et al.
Blood Advances|July 12, 2022
Venetoclax enhances the efficacy of therapeutic antibodies in B-cell malignancies by augmenting tumor cell phagocytosisFotini Vogiatzi, Julia Heymann, Kristina Müller, et al.
Gastroenterology|October 15, 2013
Nuclear death receptor TRAIL-R2 inhibits maturation of let-7 and promotes proliferation of pancreatic and other tumor cellsVerena Haselmann, Alexandra Kurz, Uwe Bertsch, et al.
The Journal of Experimental Medicine|December 17, 2021
Inhibition of ADAM17 impairs endothelial cell necroptosis and blocks metastasisJulia Bolik, Freia Krause, Marija Stevanovic, et al.
Pageof 8

Showing results (61-70 of 73) with videos related to

Sort By:
Pageof 8
Molecular and Cellular Biology|August 17, 2016
Differences and Similarities in TRAIL- and Tumor Necrosis Factor-Mediated Necroptotic Signaling in Cancer CellsJustyna Sosna, Stephan Philipp, Johaiber Fuchslocher Chico, et al.
Cancer Research|March 5, 2008
Anti-tumor necrosis factor therapy inhibits pancreatic tumor growth and metastasisJan-Hendrik Egberts, Vera Cloosters, Andreas Noack, et al.
Blood|May 27, 2011
Toso regulates the balance between apoptotic and nonapoptotic death receptor signaling by facilitating RIP1 ubiquitinationXuan-Hung Nguyen, Philipp A Lang, Karl S Lang, et al.
Autophagy|April 13, 2016
Excess sphingomyelin disturbs ATG9A trafficking and autophagosome closureElisabeth Corcelle-Termeau, Signe Diness Vindeløv, Saara Hämälistö, et al.
The European Respiratory Journal|April 22, 2022
Stimulation of the EP<sub>3</sub> receptor causes lung oedema by activation of TRPC6 in pulmonary endothelial cellsTian Jiang, Rudi Samapati, Sergej Klassen, et al.
Cardiovascular Research|June 13, 2014
RIP3, a kinase promoting necroptotic cell death, mediates adverse remodelling after myocardial infarctionMark Luedde, Matthias Lutz, Natalie Carter, et al.
Oncotarget|April 25, 2015
TRAIL-R2 promotes skeletal metastasis in a breast cancer xenograft mouse modelHendrik Fritsche, Thorsten Heilmann, Robert J Tower, et al.
Blood Advances|July 12, 2022
Venetoclax enhances the efficacy of therapeutic antibodies in B-cell malignancies by augmenting tumor cell phagocytosisFotini Vogiatzi, Julia Heymann, Kristina Müller, et al.
Gastroenterology|October 15, 2013
Nuclear death receptor TRAIL-R2 inhibits maturation of let-7 and promotes proliferation of pancreatic and other tumor cellsVerena Haselmann, Alexandra Kurz, Uwe Bertsch, et al.
The Journal of Experimental Medicine|December 17, 2021
Inhibition of ADAM17 impairs endothelial cell necroptosis and blocks metastasisJulia Bolik, Freia Krause, Marija Stevanovic, et al.
Pageof 8